2 new biomarkers can help predict preeclampsia risk

SYDNEY: Researchers have found that two newly discovered biomarkers can help assess the risk of preeclampsia, a devastating disorder that occurs very suddenly in the second half of pregnancy and causes severe health problems for both mother and baby, says a study. Preeclampsia can cause high blood pressure and organ failure in mothers and lead to preterm births and even stillbirth. It also increases the risk of developing life-long chronic diseases such as diabetes and heart disease. The two novel biomarkers, called FKBPL and CD44, have the potential to change the way the condition is managed, according to the study published in the Journal of Clinical Endocrinology and Metabolism. The biomarkers can be used to diagnose and assess the risk of getting preeclampsia in both early and late pregnancy, "in women who otherwise appear healthy", said study senior author Lana McClements from the University of Technology Sydney in Australia. (IANS)  

Also Watch: Flood Affects 100 Families in Samguri